1.Ared WP,et al.An IL-1 inhibitorfrom human monocytes production and characterization of biologic properties.JImmunol,1980;143:1851

2.Baggiolini M and Dahinden CA.CCchemokines in allergic inflammation.Immunol Today 1994;15(3):127

3.Balkwill FR and　Burke F.The cytokine network.ImmunolToday,1989;10(9):299

4.Bazan JF.Haemopoietic receptorsand helical cytokines .Immunol Today,1990;11(10):350

5.Cannon J G,et al.Circulatinginterleukin-1 and tumor necrosis of tumors.PNAS,1975;72:3666

7.Chan SH,et al.Induction ofinterferon γ production by natural killer cell stimulatoryfactor:characterization of the responder cells and synergy with other inducers.JExp Med,1991;173:869

8.Chen WF,et al.IL-10:A novelcytotoxic T cell diffeentiation factor.J Immunol,1991;147(2):528

9.Cosman D,et al.A new cytokinereceptor superfamily.TIBS,1990;15-July:265

10.Dinarello CA.Interleukin 1 andinterleukin-1antagonism.Blood,1991;77(8):1627

11.Dower SK,et al.Molecularcharacterization of two types of interleukin-1 recep-tor coding peptide onmurine and human cells.J Leukoc Biol(suppl.),1990;1:103

12.Durum SK and Mealy K.Hiltonhead revisited-cytokine explosion of the80s takes shape for the 90s.ImmunolToday,1990;11(4):103

13.Durum SK,et al.New cytokinesand receptors nake their debut in SanAntonio.Immunol Today,1991;12(2):54

14.Edward A,et al.How B and　Tcells talk to each other.Nature,1994;367:425

15.Eisenberg SP.et al.Primarystructure and funtional expression from complementary DNA of a human inteleukin1 receptor antagonist Nature,1990;3:341

16.Engelmann H,et al.A Tumornecrosis factor binding protein purified to homogeneity from human urineprotects cells from tumor necrosis factor toxicity.J Biol Chem 1989;264:11974

17.Fiorentino DF,et al.IL-10 actson the antigen-presenting cell to inhibit cytokine production by Th1 cells.JImmunol,1991;146(10):3444

18.Fong Y,et al. Antibodies tocachetin/TNF reduce IL-1β and IL-6 appearance during lethal bacteremia J ExpMed 1989;170:1627

19.Gasson JC.Molecular physiologyof granulocyte-macrophage colony-stimulating factor.Blood,1991;77(6):1131

20.Gately MK,et al.Synergybetween recombinant interleukin 2(r IL-2)and IL-2 depleted lymphokinecontaining supernatants in facilitating allogeneic human cytolytic T lymphocyteresponses in vitro.j Immunol,1986;136:1274

21.Gately MK,et al.Regulation ofhuman lymphocyte proliferation by a heterodimeric cytokine,IL-12(cyotoxiclymphocyte maturation factor).j Immunol,1991;147:874

22.Gubler V,et al.Coexpression oftwo distinct genesis requird to generate secreted bioactive cytotoxiclymphocyte maturation factor.PNAS,1991;88:4143

23.Hayashida K,et al.Molecularcloning of a second subunit of the receptor for human granulocyte-macrophagecolony-stimulating factor(GM-CSF):reconstitution of a high-affinity GM-CSfreceptor.PNAS,1990;87:9655

24.Himeno T,et al.Expression ofendogenous tumor necrosis factor.Cancer Res,1990;50:4941

25.Hirano T,et al.Biological andclinical aspects of interleukin 6.Immunol Today,1990;11(12):443

26.Horuk R.Theinterleukin-8-receptor family:from chemokines to malaria.ImmunolToday,1994;15(4):

27.Humnum CH et al.Interleukin-1receptor antagonist activity of a human interleukin-1inhibitor.Nature,1990;343:336

28.James K.Interaction betweencytokines and α2macroglobulin.Immunol Today,1990;11(50:163

29.Kishimoto T.The biology ofinterleukin-6.Blood,1989;74:1

tory factor(NKSF),a cytokine withmultiple biologic effects on human lymphocytes.J Exp Med 1989;170:827

31.KrantzS.Erythropoietin.Blood,1991;77(3):419

32.Liu Y and MullbacherA.Hypothesis:immunological help is reciprocally delivered between differentsubpopulations of lymphocytes.Scand j Immunol,1989;30:277

33.Lowenthal JM,et al.Binding andinternalization of interleukin 1 by Tcells direct evidence for high and lowaffinity classes of interleukin-1receptor.J Exp Med 1986;164:1060

34.Moore KW,et al.Homology ofcytokine synthesis inhibtory factor(IL-10)to the Epstein-Barr virus geneBCRFI.Science,1990;248:1230

35.Morgan RA,et al.Selective invitro growth of t lymphocytes.Science,1976;193:1007

36.Murphy PM.The molecularbiology of leukocyte chemoattractant receptors.Annu Rev Immunol,1994;12:593

37.Musash M,et al.Direct andsynergistic effects of interleukin 11 on murine hemopoiesis inculture.PNAS,1991;88:765

38.NacNeil IA,et al.IL-10,A novelgrowth factor for mature and immatureT cell.J Immunol,1990;145:4167

39.Namen AE,et al.Stimulation ofB-cell progenitors by cloned murine interleukin 7.Nature,1988;33:571

40.Paul SR,et al.Molecularcloning of a cDNA encoding interleukin 11,a stromal cell-derived lymphopoieticand hematopoietic cytokine.PNAS,1990;87:7512

41.Pizzolo G,et al.Solubleinterleukin 2 receptor in the serum of patients with Hodgkin‘s disease.Br JCancer 1987;55:427

42.Ralop P.A summary of cytokineaspects of the intermational symposium of molecular hematology.1990;Lymphokineand Cytokine research,1991;10(1):77

43.Rot A.Endothelial cell bindingof NAP-1/IL-8 role in neutrophil emigration.Immunol Today 1992;13(8):291

44.Rubin LA,et al.The solubleinterlenkin-2 receptor biology,function and clinical application.Annals ofInternal.Medicine 1990;113(8):619

45.Rubin LA,et al.Solubleinterleukin 2 receptors are released from activated human　lymphoid cells in vitro.J Immunol.1985;135:3172

46.Sims JE,et al.cDNA expressioncloning of the IL-1 receptor,a member of the immunoglobulin superfamily.Science1988;241:585

47.SmithKA.Interleukin-2:inception,impact and implications.Science,

1988;240:1169

48.Snouwaert JN,et al.Effects ofsite-specific mutations on biologic activity of recombinant human IL-6.JImmunol,1991;146(2):585

49.Stern AS,et al.Purification tohomogencity and　partialcharacterization of cytotoxic lymphocyte maturation factor from humanB-lypmhoblastoid cell.PNAS,1990;87:6808

50.Stotter H,et al.IL-7induceshuman lymphokine-activated killer cell activity and is regulated by IL-4.JImmunol 1991;146(1):150

51.Takaki S,et al.Molecularcloning and expression of the murine interleukin-5 receptor.EMBO,1990;(13):4367

52.Taub DD and OppenheimJJ.Review of the chemokine meeting the third international symposium ofchemotactic cytokines.Cytokine,1993;5(3):175

53.Uckun FM,et al.Interleukin 7receptor ligation stimulates tyrosine phosphorylation,inositol phospholipidturnover,and clonal proliferation ofhuman B-cell precursors.PNAS,1991;88:3589

54.Uyttenhove C,et al.Functionaland structural characterization of P40,a mouse glycoprotein with T cell-growthfactor activity.PNAS,1988;85:6934

55.William E,et al.Structure andfunctional expression of a human interleukin-8 receptor.Science,1991;253:1278

56.Wong HL,et al.Characterizationof a factor(s) which synergizes with recombinant interleukin 2 promotingallogenic human cytolytic T-lymphocyte responses in vitro.CellImmunol,1988;11:39

57.Xing X and Yong SC:Humanrecombinant IL-3 is a growth factor for normal B cells.JImmunol,1992;148(2):491

58.Yin T,et al.Involvement ofIL-6 signal transducer gp130 in IL-11-mediated signal transduction.JImmunol,1993;151:2555

59.侯云德.干扰素的不同亚型与临床应用。中国生物物品学杂志1991；6（4）：145

60.曹广文、杜平.生药活性多糖对淋巴细胞/细胞素的调节与抗肿瘤作用。免疫学杂志，1992；8（4）：273

61.孙红、施渭康.白血病抑制因子.细胞生物学，1994；16（2）49

62.段海清、黄翠芳.抑瘤素M研究进展.因外医学免疫学分册，1994；17（4）：185

63.朱学军、曹雪涛.肿瘤坏死因子拮抗剂的种类性质及其治疗作用.国外医学免疫分册，1994；17（1）：21

64.舒翠玲、金伯泉.白细胞介素12（IL-12）的研究概况.免疫学杂志，1992；8（2）：133

65.孙忱、金伯泉.可溶性细胞因子受体研究进展.国外医学免疫学分册，1994；17（2）：70

66.孙凯、金伯泉.细胞因子受体中的共用链现象及信号转导

67.黄传书、金伯泉.IL-3、IL-5和GM-CSF受体研究的进展。国外医学免疫学分册，1995；18（3）：121

68.张新海、金伯泉. 趋化因子研究进展-趋化因子家族（一）。国外医学免疫学分册，1995；18（3）：130